<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for : "Sickle cell" AND "CRISPR"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells.</h4><p><a href="https://www.biorxiv.org/content/10.1101/335729v1">Link</a></p><p><b>Date:</b> 2018-05-31</p><p><b>Authors:</b> Jennifer Chung ... Mark A Dewitt</p><p><b>Downloads:</b> 731</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Sickle Cell Disease and beta-thalassemia, which are caused by defective or deficient adult beta-globin (HBB) respectively, are the most common serious genetic blood diseases in the world.  Expression of the fetal beta-like globin, also known as gamma-globin, can ameliorate both disorders by serving in place of the adult beta-globin.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31147717">Link</a></p><p><b>Date:</b> 05/30/2019</p><p><b>Authors:</b> So Hyun Park ...  Gang Bao</p><p><b>Journal:</b> Nucleic Acids Res.</p><p><b>IF (7 or above):</b> 11.14</p><p><b>Relevance Score:</b> 0.71</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Sickle cell disease (SCD) is a monogenic disorder that affects millions worldwide.  Allogeneic hematopoietic stem cell transplantation is the only available cure.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Renal medullary carcinomas depend upon SMARCB1 loss and are sensitive to proteasome inhibition</h4><p><a href="https://www.biorxiv.org/content/10.1101/487579v1">Link</a></p><p><b>Date:</b> 2018-12-05</p><p><b>Authors:</b> Andrew L. Hong ... William C. Hahn</p><p><b>Downloads:</b> 507</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Renal medullary carcinoma (RMC) is a rare and deadly kidney cancer in patients of African descent with sickle cell trait.  Through direct-to-patient outreach, we developed genomically faithful patient-derived models of RMC.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/32095533">Link</a></p><p><b>Date:</b> 02/25/2020</p><p><b>Authors:</b> Leslie Weber ...  Annarita Miccio</p><p><b>Journal:</b> Sci Adv</p><p><b>IF (7 or above):</b> 12.53</p><p><b>Relevance Score:</b> 0.57</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Sickle cell disease (SCD) is caused by a single amino acid change in the adult hemoglobin (Hb) β chain that causes Hb polymerization and red blood cell (RBC) sickling.  The co-inheritance of mutations causing fetal γ-globin production in adult life hereditary persistence of fetal Hb (HPFH) reduces t ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: ATF4 mediates fetal globin upregulation in response to reduced β-globin</h4><p><a href="https://www.biorxiv.org/content/10.1101/2020.01.15.905943v1">Link</a></p><p><b>Date:</b> 2020-01-15</p><p><b>Authors:</b> Mandy Boontanrart ... Jacob E. Corn</p><p><b>Downloads:</b> 407</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Fetal development and anemias such as β-hemoglobinopathies trigger rapid production of red blood cells in a process known as stress erythropoiesis.  Cellular stress prompts differentiating erythroid precursors to express high levels of fetal γ-globin, which has suggested strategies to treat hemoglobinopathies such as thalassemia and sickle cell disease.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31980609">Link</a></p><p><b>Date:</b> 01/25/2020</p><p><b>Authors:</b> Kailong Li ...  Jian Xu</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.57</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Tissue-specific gene expression requires coordinated control of gene-proximal and -distal cis-regulatory elements (CREs), yet functional analysis of gene-distal CREs such as enhancers remains challenging.  Here we describe CRISPR/dCas9-based enhancer-targeting epigenetic editing systems, enCRISPRa a ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31004025">Link</a></p><p><b>Date:</b> 04/20/2019</p><p><b>Authors:</b> Xiaofei Yu ...  Gordon D Ginder</p><p><b>Journal:</b> Haematologica</p><p><b>IF (7 or above):</b> 7.53</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> As high fetal hemoglobin levels ameliorate the underlying pathophysiological defects in sickle cell anemia and beta (β)-thalassemia, understanding the mechanisms that enforce silencing of fetal hemoglobin postnatally offers the promise of effective molecular therapy.  Depletion of the Nucleosome Rem ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Monkeys mutant for PKD1 recapitulate human autosomal dominant polycystic kidney disease.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31822676">Link</a></p><p><b>Date:</b> 12/11/2019</p><p><b>Authors:</b> Tomoyuki Tsukiyama ...  Masatsugu Ema</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Autosomal dominant polycystic kidney disease (ADPKD) caused by PKD1 mutations is one of the most common hereditary disorders.  However, the key pathological processes underlying cyst development and exacerbation in pre-symptomatic stages remain unknown, because rodent models do not recapitulate crit ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31299082">Link</a></p><p><b>Date:</b> 07/12/2019</p><p><b>Authors:</b> Pin Lyu ...  Baisong Lu</p><p><b>Journal:</b> Nucleic Acids Res.</p><p><b>IF (7 or above):</b> 11.14</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Transient expression of the CRISPR/Cas9 machinery will not only reduce risks of mutagenesis from off-target activities, but also decrease possible immune response to Cas9 protein.  Building on our recent developing of a system able to package up to 100 copies of Cas9 mRNA in each lentivirus-like par ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Divalent cations promote TALE DNA-binding specificity.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31863586">Link</a></p><p><b>Date:</b> 12/21/2019</p><p><b>Authors:</b> Luke Cuculis ...  Charles M Schroeder</p><p><b>Journal:</b> Nucleic Acids Res.</p><p><b>IF (7 or above):</b> 11.14</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Recent advances in gene editing have been enabled by programmable nucleases such as transcription activator-like effector nucleases (TALENs) and CRISPR-Cas9.  However, several open questions remain regarding the molecular machinery in these systems, including fundamental search and binding behavior  ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: LSD1/KDM1A inhibitors in clinical trials: advances and prospects.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31801559">Link</a></p><p><b>Date:</b> 12/05/2019</p><p><b>Authors:</b> Yuan Fang ...  Bin Yu</p><p><b>Journal:</b> J Hematol Oncol</p><p><b>IF (7 or above):</b> 8.71</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Histone demethylase LSD1 plays key roles during carcinogenesis, targeting LSD1 is becoming an emerging option for the treatment of cancers.  Numerous LSD1 inhibitors have been reported to date, some of them such as TCP, ORY-1001, GSK-2879552, IMG-7289, INCB059872, CC-90011, and ORY-2001 currently un ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Noncoding RNAs in cancer therapy resistance and targeted drug development.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31174564">Link</a></p><p><b>Date:</b> 06/08/2019</p><p><b>Authors:</b> Wen-Tao Wang ...  Yue-Qin Chen</p><p><b>Journal:</b> J Hematol Oncol</p><p><b>IF (7 or above):</b> 8.71</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Noncoding RNAs (ncRNAs) represent a large segment of the human transcriptome and have been shown to play important roles in cellular physiology and disease pathogenesis.  Increasing evidence on the functional roles of ncRNAs in cancer progression emphasizes the potential of ncRNAs for cancer treatme ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Enhancement of LIN28B-induced hematopoietic reprogramming by IGF2BP3.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31221665">Link</a></p><p><b>Date:</b> 06/21/2019</p><p><b>Authors:</b> Saifeng Wang ...  Stefan A Muljo</p><p><b>Journal:</b> Genes Dev.</p><p><b>IF (7 or above):</b> 8.23</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Fetal hematopoietic stem and progenitor cells (HSPCs) hold promise to cure a wide array of hematological diseases, and we previously found a role for the RNA-binding protein (RBP) Lin28b in respecifying adult HSPCs to resemble their fetal counterparts.  Here we show by single-cell RNA sequencing tha ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Collateral damage: benchmarking off-target effects in genome editing.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31159845">Link</a></p><p><b>Date:</b> 06/04/2019</p><p><b>Authors:</b> Dana Carroll</p><p><b>Journal:</b> Genome Biol.</p><p><b>IF (7 or above):</b> 12.16</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> This editorial discusses what levels of off-target effects can be tolerated in genome editing, in the context of various types of applications. .</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31924806">Link</a></p><p><b>Date:</b> 01/11/2020</p><p><b>Authors:</b> Aditya Mithal ...  Gustavo Mostoslavsky</p><p><b>Journal:</b> Nat Commun</p><p><b>IF (7 or above):</b> 11.80</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Efficient generation of human induced pluripotent stem cell (hiPSC)-derived human intestinal organoids (HIOs) would facilitate the development of in vitro models for a variety of diseases that affect the gastrointestinal tract, such as inflammatory bowel disease or Cystic Fibrosis.  Here, we report  ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Glycosylation in health and disease.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/30858582">Link</a></p><p><b>Date:</b> 03/12/2019</p><p><b>Authors:</b> Colin Reily ...  Jan Novak</p><p><b>Journal:</b> Nat Rev Nephrol</p><p><b>IF (7 or above):</b> 10.72</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The glycome describes the complete repertoire of glycoconjugates composed of carbohydrate chains, or glycans, that are covalently linked to lipid or protein molecules.  Glycoconjugates are formed through a process called glycosylation and can differ in their glycan sequences, the connections between ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31640748">Link</a></p><p><b>Date:</b> 10/23/2019</p><p><b>Authors:</b> Annie N Cowell ...  Elizabeth A Winzeler</p><p><b>Journal:</b> Genome Med</p><p><b>IF (7 or above):</b> 10.47</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> A major advance in antimalarial drug discovery has been the shift towards cell-based phenotypic screening, with notable progress in the screening of compounds against the asexual blood stage, liver stage, and gametocytes.  A primary method for drug target deconvolution in Plasmodium falciparum is in ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: The genetics of human hematopoiesis and its disruption in disease.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31313878">Link</a></p><p><b>Date:</b> 07/17/2019</p><p><b>Authors:</b> Erik L Bao ...  Vijay G Sankaran</p><p><b>Journal:</b> EMBO Mol Med</p><p><b>IF (7 or above):</b> 10.28</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Hematopoiesis, or the process of blood cell production, is a paradigm of multi-lineage cellular differentiation that has been extensively studied, yet in many aspects remains incompletely understood.  Nearly all clinically measured hematopoietic traits exhibit extensive variation and are highly heri ....</p></div></td></div></tr><tr><div class="row"><td></td><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31950591">Link</a></p><p><b>Date:</b> 01/17/2020</p><p><b>Authors:</b> Sean G Rudd ...  Nikolas Herold</p><p><b>Journal:</b> EMBO Mol Med</p><p><b>IF (7 or above):</b> 10.28</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> The deoxycytidine analogue cytarabine (ara-C) remains the backbone treatment of acute myeloid leukaemia (AML) as well as other haematological and lymphoid malignancies, but must be combined with other chemotherapeutics to achieve cure.  Yet, the underlying mechanism dictating synergistic efficacy of ....</p></div></td></div></tr></table></div><hr></div></body></html>